Screener / SEC EDGAR /CIK 0001125376 /10-K filed Feb 4, 2026, compared with Feb 5, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Skilled Nursing Care Facilities

Ensign Group, Inc ENSG

Compare with peers Embed
SEC comment letters, last 20 years

1 review of ENSG's filings by SEC staff

UPLOAD and CORRESP
Reviews 1 latest letter May 19, 2017
Questions asked 1 each answered in the company's own letter
No closing letter 0 reviews without a letter saying the staff completed it

When the SEC's staff reviews a filing, it writes to the company with numbered questions, and the company answers each one in a letter. SEC publishes the exchange once the review is over, at least 20 business days later. A question is not an accusation; most reviews end with the company adding detail to its next filing.

How the reviews went

Every review on EDGAR, from the first staff letter to the letter that closes it

  1. 1. Staff letters 1 UPLOAD
  2. 2. Questions in them 1 numbered comments
  3. 3. Company replies 2 CORRESP
  4. 4. Reviews closed 1 of 1 closing letter

Half the closed reviews took 63 days or less from the first letter to the closing letter.

Form 10-K

2017-05-19 to 2017-07-21 · 1 question · 1 letter from the SEC, 2 from the company
Review closed 2017-07-21
Non-GAAP measuresLeases
Item 6. Selected Financial Data · Other Non-GAAP Financial Data, page 68-70
SEC asked
We note that you exclude lease expense from EBITDAR and adjusted EBITDAR. Please explain to us why this is not a normal, recurring operating expense necessary to operate your business. See Question 100.01 of the updated Non-GAAP Compliance and Disclosure Interpretations issued on May 17, 2016.
ENSG answered
We respectfully acknowledge the Staff's comment and we have reviewed the guidance within Question 100.01 of the updated Non-GAAP Compliance and Disclosure Interpretations issued on May 17, 2016. We have historically disclosed EBITDAR in our filings as we believe it is a critical performance measure that helps in analyzing the financial performance of our businesses independent of the capital structure of our operations, which can vary significantly among our operations and the operations of our competitors.
Rest of the answer

We currently operate 215 facilities, of which 50 are owned and 165 are leased through long-term lease arrangements. We incur facility rent expense on our 165 operating lease facilities. Of our owned operations, some of these assets have long-term mortgages, whereby the principal and interest payments are not included in the calculation of EBITDAR. Other operations that are unlevered, result in no rent or interest expense. On all assets, we record depreciation expense, which is not included in the calculation of EBITDAR. If we compare operating performance including rent expense, but excluding depreciation, the analysis would favor owned operations and distort the operating performance of leased operations in a negative trend. In addition, certain of our leases include contingent rent clauses. If we were to include rent expense, the performance of our leased operations would not be comparable within our owned operations as the financial impact of contingent rent varies from period to period. We also noted that our home health and hospice segment does not utilize a facility to perform its healthcare services.

Therefore, we refer to EBITDAR margins to assist in comparing facility driven operations to non-facility operations. The utilization of EBITDAR allows us to compare operating results across all capital structures.

Another use of EBITDAR is to provide a meaningful comparison with our peers, to account for the differences in debt structures and leasing arrangements within our industry and to highlight the operating margin differences between business models. EBITDAR is a well understood metric widely used by investors, research analysts, rating agencies and other stakeholders, to evaluate the overall operating performance of companies in our industry, without regard to items such as rent expense, interest expense, depreciation and amortization. These items can vary substantially from company to company depending on the book value of assets, capital structure and method by which assets were acquired. In addition, EBITDAR also helps investors evaluate and compare the results of our operations from period to period by removing the impact of our capital structure and asset base from operating results. In fact, investors and analysts look to, and desire us to present, EBITDAR in their evaluation of our financial performance and comparison of our performance over time. We have included in Exhibit A examples of some of our analyst reports’ on our recent performance results, which reference the fact that they are utilizing EBITDAR as a performance metric.

Management considers cash outlay for both interest and rent expense as capital structure costs. A leased operation incurs rent expense while a levered owned operation incurs interest expense. Interest expense reflects similarities to rent expense when comparing these cash outlays. While rent expense is presented as a cash operating expense, it is not considered by management in assessing both consolidated and individual operation performance. Rather, rent expense is a cost of the Company's capital structure when management makes the financial decision to lease a facility. In the context of this financial measure, we do not believe that the adjustments related to operating leases are misleading or are inappropriately adjusting for normal, recurring, cash operating expenses.

One of the important elements of our business strategy is to grow our operations through organic growth and acquisitions. Our acquisition focus is to purchase or lease operations that are complementary to our current operations, accretive to our business or otherwise advance our strategy. When determining whether a potential operation should be added to our portfolio companies, we exclude depreciation and amortization, interest, rent and income tax expense from the operating performance results to neutralize the effect of the capital structure decisions in the potential acquisition. EBITDAR is a financial performance metric that helps us evaluate the core operating performance of the potential acquisition and to decide whether we transform the operation’s financial and clinical performance.

We also use EBITDAR in evaluating the operating performance of our individual operations. EBITDAR is useful in this regard as the measurement removes the impact of the Company's capital structure (interest and lease expense) and its asset base (depreciation expense), the cost of which is outside the control of the employees responsible for operating our facilities. Accordingly, we use EBITDAR internally to evaluate the operating performance of individual operations and the employees responsible for operating performance. Additionally, we have historically established compensation programs for our leaders that are partially based upon the achievement of Adjusted EBITDAR and EBIT targets.

Adjusted EBITDAR is calculated as EBITDAR adjusted for certain non-core business items. These adjustments are excluded as they are variable in nature or do not represent current revenues or cash expenditures. We believe that the presentation of adjusted EBITDAR provides important supplemental information to management and investors to evaluate our operating performance.

We acknowledge that EBITDAR and Adjusted EBITDAR are non-GAAP measures and should be considered in addition to, and not as a substitute for, net earnings and other financial measures in accordance with GAAP. In future filings, we will clarify the disclosure, including the additional information above, to describe the purpose for excluding rent expense from the calculation of EBITDAR and Adjusted EBITDAR. This rationale includes our view that mortgage loans and operating leases are capital structure arrangements and that the impact of these financial measures should be treated consistently to assess the performance of our core operations and promote comparability with our peers. Attached in Exhibit B are portions of our Annual Report on the Form 10-K that reflect how we propose to disclose the additional information regarding EBITDAR and Adjusted EBITDAR in the future.

Read in the reply
In its next report

First report after the company's reply of Jun 2, 2017: 10-Q filed Aug 3, 2017 ↗, against the 10-Q filed May 1, 2017 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: company letter, Jun 29, 2017, closing letter, 2017-07-21

Letters without questions

Other letters

UPLOAD and CORRESP
2 other letters: notices that a filing will not be reviewed, requests to declare a registration effective, and the like
  • Oct 1, 2019 · SEC: review completed · ENSIGN GROUP, INC · Form 10-K for Fiscal Year Ended December 31, 2018 · Filed February...
  • Sep 26, 2019 · ENSG: letter to the SEC · The Ensign Group, Inc. · Quarterly Report on Form 10-Q for the three and six months...

From the SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), 6 letters filed since 2017-05-19. Questions and answers are matched by their numbers; topics come from words in each question. The reports are compared word for word (same form, before the first SEC letter against the first report after the company's reply). No AI.

Sources

The SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), matched question by question. No AI.

Also

Filings: the letters in the filing list.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ENSG/export.csv") into a cell.

Next in Owners and insiders:Insider trades
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.